Sol Gel Technologies Ltd
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopust… Read more
Sol Gel Technologies Ltd (SLGL) - Total Assets
Latest total assets as of September 2025: $34.59 Million USD
Based on the latest financial reports, Sol Gel Technologies Ltd (SLGL) holds total assets worth $34.59 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sol Gel Technologies Ltd - Total Assets Trend (2014–2024)
This chart illustrates how Sol Gel Technologies Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sol Gel Technologies Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Sol Gel Technologies Ltd's total assets of $34.59 Million consist of 87.3% current assets and 12.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 54.4% |
| Accounts Receivable | $3.60 Million | 10.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Sol Gel Technologies Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sol Gel Technologies Ltd's current assets represent 87.3% of total assets in 2024, an increase from 35.2% in 2014.
- Cash Position: Cash and equivalents constituted 54.4% of total assets in 2024, up from 24.9% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 10.0% of total assets.
Sol Gel Technologies Ltd Competitors by Total Assets
Key competitors of Sol Gel Technologies Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Sol Gel Technologies Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Sol Gel Technologies Ltd generates 0.32x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Sol Gel Technologies Ltd is currently not profitable relative to its asset base.
Sol Gel Technologies Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.15 | 5.81 | 8.95 |
| Quick Ratio | 5.15 | 5.81 | 8.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $25.50 Million | $ 31.42 Million | $ 47.44 Million |
Sol Gel Technologies Ltd - Advanced Valuation Insights
This section examines the relationship between Sol Gel Technologies Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.07 |
| Latest Market Cap to Assets Ratio | 1.22 |
| Asset Growth Rate (YoY) | -20.8% |
| Total Assets | $35.85 Million |
| Market Capitalization | $43.86 Million USD |
Valuation Analysis
Above Book Valuation: The market values Sol Gel Technologies Ltd's assets above their book value (1.22 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Sol Gel Technologies Ltd's assets decreased by 20.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sol Gel Technologies Ltd (2014–2024)
The table below shows the annual total assets of Sol Gel Technologies Ltd from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $35.85 Million | -20.85% |
| 2023-12-31 | $45.29 Million | -2.88% |
| 2022-12-31 | $46.63 Million | -32.61% |
| 2021-12-31 | $69.19 Million | +16.95% |
| 2020-12-31 | $59.16 Million | -3.49% |
| 2019-12-31 | $61.30 Million | -12.03% |
| 2018-12-31 | $69.68 Million | +354.99% |
| 2017-12-31 | $15.31 Million | +39.42% |
| 2016-12-31 | $10.98 Million | +33.25% |
| 2015-12-31 | $8.24 Million | +245.52% |
| 2014-12-31 | $2.39 Million | -- |